The characters shown are real patients and the required consent to use their stories has been obtained from the patients and families. Photographs are for illustrative purposes only.
Over the course of two connected symposia, neuromuscular experts discussed the latest SMA evidence and shared their perspectives on what this means for treating adults with SMA.
Using real-life cases studies of adult patients with SMA, Dr. Konersman and Dr. Kostera-Pruszczyk examined the challenges of treatment access and outcome expectations.
In the second symposium, the doctors considered approaches in defining response to treatment for adults with SMA, reviewing two case studies from their respective clinics.
University of California San Diego (UCSD) and Rody Children’s Hospital, San Diego, CA, USA
Central Clinical Hospital University Clinical Center of the Medical University of Warsaw, Warsaw, Poland
Stabilisation of motor function is an important goal for adults living with SMA.1 Learn more about the differences in treatment goals between adults and children living with SMA.
Now that supportive care is improving, care expectations are even greater. Explore Biogen’s website to learn how discussing new care options with your patients can make a difference.
Learn more about Biogen's participation in
ICNMD and Neurology events.
Check out the Biogen-sponsored symposia, publications and posters about SMA from this and other past congresses at: SMA scientific lounge
1. 1. Rouault F, et al. Disease impact on general well-being and therapeutic expectations of European Type II and Type III spinal muscular atrophy patients. Neuromuscul Disord 2017;27(5):428-438.